Alignment Healthcare grants 25,015 RSUs to executive

Mansour Adnan R. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Mansour Adnan R. reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare reported that Chief Digital Officer Adnan R. Mansour received a grant of 25,015 restricted stock units of Common Stock on March 13, 2026. These RSUs vest in roughly one-third increments on each of the first three anniversaries of the grant date, if he continues serving the company. After this award, he directly holds 48,456 shares or units tied to Alignment Healthcare stock. This transaction reflects equity-based compensation rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 25,015 shares

Grant/Award 1 txn

Insider Mansour Adnan R.

Role Chief Digital Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	25,015	$0.00	$0.00

Holdings After Transaction: Common Stock — 48,456 shares (Direct)

Footnotes (1)

1. F1. Represents 25,015 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Alignment Healthcare (ALHC) disclose in this Form 4 filing?

Alignment Healthcare disclosed that Chief Digital Officer Adnan R. Mansour received 25,015 restricted stock units as equity compensation. The award is in Common Stock and increases his directly held Alignment-related shares or units to 48,456 after the transaction.

How many Alignment Healthcare (ALHC) RSUs were granted to Adnan R. Mansour?

Adnan R. Mansour was granted 25,015 restricted stock units tied to Alignment Healthcare Common Stock. Each unit represents the right to receive one share, subject to vesting conditions based on continued service with the company over time.

What is the vesting schedule for Adnan R. Mansour’s ALHC restricted stock units?

The 25,015 restricted stock units vest in approximately one-third increments on each of the first three anniversaries of the grant date. Vesting is contingent on Mansour’s continued service with Alignment Healthcare through each applicable vesting date.

Did Adnan R. Mansour buy or sell Alignment Healthcare (ALHC) stock in the market?

The filing shows a grant of 25,015 restricted stock units at a reported price of $0.00 per share, indicating compensation rather than an open-market trade. There are no reported open-market purchases or sales in this specific Form 4 transaction.

How many Alignment Healthcare (ALHC) shares does Adnan R. Mansour hold after this grant?

Following the award, Adnan R. Mansour is reported to directly hold 48,456 shares or units related to Alignment Healthcare Common Stock. This total includes the newly granted restricted stock units as reflected in the post-transaction ownership figure.

What does a Form 4 RSU grant mean for Alignment Healthcare (ALHC) investors?

The Form 4 reflects a routine equity compensation grant of 25,015 restricted stock units to a senior executive. It aligns part of the Chief Digital Officer’s compensation with Alignment Healthcare’s stock performance, without indicating any open-market buying or selling activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 05:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mansour Adnan R.

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY DRIVE

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Digital Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		25,015(1)	A	$0	48,456	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 25,015 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Adnan R. Mansour	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.